consolidated net profit of THB 5,983 mn, an increase of 155.4% from the same period of the previous year (YoY). Total revenue stood at THB 11,198 mn, an increase of 53.0% YoY. Excluding a non-recurring item
the year 2018 ended March 31, 2018 as follows: Company’s Performance (unit: million Baht ) 2018 (Quarterly) Percentage 2017 (Quarterly) Percentage Total income and other income 5.94 100.00 12.97 100.00
9 months of the year 2018 ended September 30, 2018 as follows: Company’s Performance (unit: million Baht ) 2018 (9 Month) Percentage 2017 (9 Month) Percentage Total income and other income 11.41
-production - - 0.61 100.00 Income from concert organization 38.84 94.92 - - Income from sales 2.08 5.08 - - Total Income 40.92 100.00 0.61 100.00 Costs for the right of co-production - - - - Costs for concert
transaction to invest in the common stock of BS Myco Biotech Company Limited that operate in the Biopharmaceutical products with purchase from Bangjak Green Energy Company Limited total 399,990 shares or 85.65
Central Pattana Public Company Limited (“The Company” or “CPN”) in 2Q19 shows total revenue of THB 9,197 mn, an increase of 0.7% and net profit stood at THB 2,470 mn, a decrease of 15.9% from the same
fully amortized cost of purchasing 34 36 40 Summary of Profit and Loss Statement 2016 2017 Change MB % MB % MB % Total Revenues 1,063.7 100.0% 1,356.3 100.0% 292.6 27.5% Cost of Services 377.9 35.5% 574.4
sale – net 307.32 311.03 -3.71 -1.19 306.04 306.79 -0.75 -0.24 Gain from exchange rate 1.92 0.14 1.78 1,251.70 1.95 0.13 1.82 1,412.40 Other income 12.56 6.42 6.13 95.47 11.74 6.22 5.52 88.87 Total
partner to expand the business of Land and Houses financial business group. The company agrees in principle to issue 7,544,961,342 new ordinary shares or 35.6169 percent of the total paid-up capital through